Clin2
NCT07095959Possibly a fitRecruiting

Ethanol vein infusion plus pulsed field ablation for paroxysmal AF

Atrial Fibrillation (AF)

Part of Heart & circulation clinical trials.

This study compares two treatments for paroxysmal atrial fibrillation (AF that comes and goes): using pulsed electric field ablation alone versus combining it with ethanol infusion into a specific vein. The goal is to see which approach works better for first-time ablation patients.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
340 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have paroxysmal atrial fibrillation (AF that comes and goes) with symptoms.
  • You are having your first-ever ablation (a treatment that uses catheters to fix the heart's electrical signals).
  • You have had at least one episode of AF lasting more than 30 seconds, confirmed by a heart monitor in the last year.
  • You are willing to be randomly assigned to one of two procedure types and can participate in follow-up visits.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07601763Recruiting
Pulsed Field Ablation for Atrial Fibrillation Treatment

This trial tests a newer ablation technique called pulsed field ablation to treat atrial fibrillation, a heart rhythm disorder. The goal is to see if this method works well and is safe for patients who need treatment.

Beijing, Beijing Municipality
NCT06647485Recruiting
Pulsed Field Ablation for Paroxysmal Atrial Fibrillation

This trial studies a new procedure called pulsed field ablation to treat brief episodes of atrial fibrillation (AFib). The goal is to see if it can help reset the heart's natural electrical system and reduce symptoms.

Aalst, Belgium
NCT07023237Not yet recruiting
3D-guided pulsed field ablation for intermittent atrial fibrillation

This study tests a newer, gentler way to fix irregular heartbeats in people with paroxysmal AF. The treatment uses special energy (pulsed fields) guided by 3D imaging to target the heart tissue causing the problem, and the goal is to restore a normal rhythm with fewer risks.

NCT07783919Not yet recruiting
Comparing two pulsed field ablation methods for atrial fibrillation

This trial compares two different ways of delivering pulsed field ablation—a newer, targeted energy that zaps abnormal heart tissue—for people with atrial fibrillation. It aims to see if a single broader application works as well as a more focused, two-step approach, and it may help you feel better if you have symptoms from this irregular heartbeat.

Herne, North Rhine-Westphalia
NCT07779369Not yet recruiting
Pulsed field ablation for atrial fibrillation

This study tests a new way to treat atrial fibrillation (AFib) using pulsed electrical energy to target the heart tissue that causes the irregular rhythm. It aims to see if this method is safe and effective for people having their first such treatment.

NCT04529785Recruiting
Tested added ethanol vein treatment during repeat atrial fibrillation ablation

This trial compares two ways to help stop atrial fibrillation during a repeat procedure: standard vein isolation only versus standard isolation plus an added medicine (ethanol) into the vein of Marshall. It aims to see whether the added step improves results when atrial fibrillation returns after a previous successful treatment.

Bruges, Please Select

Hear when a new Atrial Fibrillation (AF) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.